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Baseline cortisol measures and
developmental pathways of anxiety in early
adolescence
Introduction
The onset of adolescence is characterized by high
levels of anxiety (1–3). Since these problems result
in considerable suﬀering and social impairment (4),
it is important to investigate aetiological mecha-
nisms and putative biological markers to identify
individuals at risk. One of the biological systems
that may play a role in anxiety is the hypothalamic–
pituitary–adrenal (HPA) axis. The HPA-axis is
activated by stressful stimuli. Under stress, hypo-
thalamic production of corticotropin-releasing
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Objective: This study investigated whether baseline cortisol measures
predicted future anxiety, and compared cortisol values of groups with
diﬀerent developmental pathways of anxiety.
Method: Cortisol levels were assessed in 1768 individuals
(10–12 years). Anxiety levels were assessed at the same age and 2 years
later.
Results: Cortisol measures did not predict future anxiety levels.
Individuals with persistent anxiety problems did not show higher
morning cortisol levels than those with persistently low, decreasing, or
increasing anxiety levels. Instead, individuals with persistently high
anxiety levels showed signiﬁcantly lower evening cortisol levels than all
other individuals. Further, participants with increasing anxiety levels
showed higher morning cortisol levels (area under the curve; AUC)
than individuals with persistently low anxiety levels.
Conclusion: The extent to which the HPA-axis – by itself – plays a role
in the aetiology of anxiety is questionable. Interactions of the HPA-
axis with other biological or environmental factors may be more
important.
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Significant outcomes
• Baseline cortisol measures did not predict anxiety levels two years later.
• Individuals with persistent anxiety problems did not show higher morning cortisol levels [area under
the curve (AUC)] than all other individuals. Instead, they showed signiﬁcantly lower evening cortisol
levels.
• Participants with increasing anxiety levels showed higher morning cortisol (AUC) levels than
individuals with persistently low anxiety levels.
Limitations
• Only baseline cortisol levels were assessed, reactivity to a psychological stressor was not assessed.
• The inﬂuence of daily stresses or stressful life-events was not measured.
• Cortisol was collected at home, which may have limited the reliability of the time points at which
cortisol samples were collected.
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hormone (CRH) increases, which stimulates the
pituitary release of adrenocorticotropin hormone
(ACTH). As a consequence, cortisol secretion from
the adrenal cortex increases. HPA-axis activity not
only changes as a result of stress, but also ﬂuctuates
during normal daily activities. In the morning, as a
result of waking up, cortisol levels rise, reaching a
peak after approximately half an hour [cortisol
awaking response (5, 6)]. After this peak, cortisol
levels begin to decrease, and continue to decrease
during the day.
Kagan et al. (7) have suggested that some
children are susceptible to developing anxiety
problems, because of a low threshold for HPA-
axis activation. In these children, stimuli would
more easily increase HPA-axis activity, resulting in
relatively high cortisol concentrations. In time,
these children would show withdrawn, anxious
behaviour, because they try to avoid the unpleasant
stress reaction to stimuli. One could therefore
expect relatively high cortisol levels in anxious
individuals. Findings of Kagan et al. (8) corrobo-
rated their hypothesis; they found that basal
cortisol levels were higher in inhibited young
children than in uninhibited ones. An inhibited
temperament represents fearful and withdrawn
behaviour (9).
However, Feder et al. (10) found evidence for
lower night-time cortisol levels in anxious children.
These ﬁndings can be interpreted in the light of a
theory by Gunnar and Vazquez (11), who hypo-
thesized that stressful inﬂuence early in life may
provoke frequent elevations in cortisol levels,
which would eventually lead to down-regulation
of components of the HPA-axis. On the basis of
this theory, and the assumption that stress in early
life is also associated with a risk for anxiety
problems (12, 13), one could expect anxiety prob-
lems to be associated with relatively low cortisol
levels. Taken together, there is still little consensus
about whether relatively high or low cortisol levels
underlie anxiety problems.
In a previous retrospective study (14), we found
that morning cortisol levels were higher in young
adolescents with persistent anxiety problems
(within ages 4 to 12) than in those with no or
only current anxiety problems. However, it is still
unclear whether the higher cortisol levels we found
in individuals with persistent anxiety problems
resulted from long-lasting anxiety problems, or
reﬂected an underlying biological vulnerability that
may have caused the anxiety problems.
Better insight in the direction of the association
between cortisol measures and anxiety problems
would be provided by prospective studies, yet such
studies are scarce. Smider et al. (15) found that
higher mean daytime cortisol levels at age 4.5
predicted internalizing problems at age 6. This one
prospective study indicates that higher basal day-
time cortisol levels at a young age may be a risk
factor for internalizing problems across a short
time interval.
Many studies in adult patients with major
depression indicated that symptoms of depression
may cause an association between the broad
dimension internalizing problems and HPA-axis
activity (11, 16). Hence, it is important to distin-
guish anxiety from depression when investigating
associations between anxiety and HPA-axis activ-
ity. To our knowledge, studies that investigated
whether cortisol measures speciﬁcally predicted
anxiety – apart from depression – in young
adolescents are lacking.
Aims of the study
Our aim was to investigate whether cortisol mea-
sures predicted future anxiety, and to compare
cortisol values of individuals with persistently high,
persistently low, decreasing, or increasing anxiety
levels. We hypothesize that: i) high cortisol levels
predict high future anxiety levels, ii) morning
cortisol levels are highest in individuals with
persistently high anxiety levels and iii) cortisol
measures would are speciﬁcally associated with
anxiety, as apart from depression.
Material and methods
Sample and procedure
This study is part of the TRacking Adolescents
Individual Lives Survey (TRAILS), a prospective
cohort study of Dutch young adolescents initially
aged 10–12 years old, who are followed biennially,
until the age of 24. TRAILS aims to chart and
explain the development of mental health from
pre-adolescence into adulthood, both at the level of
psychopathology, and at the level of underlying
vulnerability and environmental risk. This study
involves data from the ﬁrst and second assessment
wave of TRAILS, which ran from, respectively,
March 2001 to July 2002, and September 2003 to
December 2004.
The TRAILS target sample consisted of young
adolescents from ﬁve municipalities in the North of
the Netherlands, including both urban and rural
areas. The exclusion criteria were: i) adolescent
incapable to participate because of mental retar-
dation or a serious physical illness or handicap and
ii) Dutch-speaking parent or parent surrogate not
available, and not feasible to administer a part of
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the measurements in parents own language. Of all
individuals who were approached (n = 3145),
6.7% were excluded. Of the remaining 2935
young adolescents, 76.0% participated in the
study (n = 2230, mean age 11.1 years, SD = 0.6,
50.8% girls). Participants did not diﬀer from those
who refused to participate with respect to the
proportion of single parent families, the prevalence
of teacher-rated problem behaviour, several soci-
odemographic variables and mental health out-
comes (17). Of the 2230 baseline participants,
96.4% (n = 2149, 51.0% girls) participated in the
second assessment wave, two to three years after
wave 1 (mean number of months 29.4, SD = 5.4,
range 16.7–48.1). Mean age at wave 2 was 13.6
(SD = 0.5). The Revised Child Anxiety and
Depression Scale (RCADS, see below) was com-
pleted at the ﬁrst and second assessment wave by
2081 individuals. At the ﬁrst wave, we obtained
cortisol samples three times on 1 day (sample 1:
directly after waking up, sample 2: half an hour
later, and sample 3: at 8.00 P.M.) in 1768 partic-
ipants. Twenty-two participants were excluded
because of use of antibiotics or corticosteriods.
To reduce the impact of outliers, cortisol values
that were above 3 SD of the mean were also
excluded. This yielded n = 1666 for sample 1
(21 excluded), n = 1683 for sample 2 (11 excluded),
and n = 1689 for sample 3 (18 excluded). All in all,
RCADS questionnaire data from both assessment
waves and at least one cortisol sample were
available for 1623 participants.
To examine possible selective attrition, a
stepwise logistic regression analysis was performed
in which the 1623 participants with available data
for this study were compared with the other
individuals who participated at wave 1. Gender,
pubertal stage, socioeconomic status, the diﬀerent
cortisol measures (sample, 1, 2, and 3), and scores
on the RCADS Total Anxiety and Depression (see
below) scales were used as predictors. Low socio-
economic status signiﬁcantly predicted attrition
(b = 0.68, P < 0.00), whereas the other predic-
tors did not. However, the eﬀect size of the entire
model was small (Cox and Snell R2 = 1.5%).
After the procedure had been fully explained,
written consent was obtained from the young
adolescents parents at both assessments waves.
The study was approved by the Central Dutch
Medical Ethics Committee.
Measures
Anxiety and co-occurring depressive problems. The
Revised Child Anxiety and Depression Scale
[RCADS (18, 19)], a revision of the Spence
Childrens Anxiety Scale [SCAS (20)], was used to
measure anxiety levels and co-occurring depressive
problems. The RCADS is a self-report question-
naire with 47 items that are scored on a 4-point
scale (0 = never, 1 = sometimes, 2 = often, 3 =
always), and covers symptoms of the following
DSM-IV disorders: separation anxiety disorder,
generalized anxiety disorder, social phobia, panic
disorder, obsessive–compulsive disorder, and
major depressive disorder (MDD). In this study,
Total Anxiety scores were computed by summing
the scores on all the anxiety items and dividing this
sum score by the number of items for which
answers had been ﬁlled in, resulting in a mean
score on all anxiety items. If more than 33% of the
items were missing, the scale score was coded as
missing. Depression (MDD) scores were computed
in a similar manner.
The internal consistencies of the scales that
were used were – respectively at wave 1 ⁄wave
2 – 0.91 ⁄0.93 for the Total Anxiety scale, and
0.72 ⁄0.81 for the Depression scale. The original
factor structure, which was originally based on data
from 1641 children and adolescents from a commu-
nity sample from Hawaii (18), was conﬁrmed by
conﬁrmatory factor analysis in the TRAILS sample
at wave 1 (ﬁt indices of NNFI=0.96, RMSEA =
0.05, and SRMR = 0.05, indicating an adequate ﬁt
to the sample data (21).
Cortisol. TRAILS participants collected three
samples of saliva with a Salivette sampling
device. Collection of cortisol in saliva is a relatively
stress-free approach that avoids confounding by
stress responses, such as those induced by
venipuncture (22). According to several authors,
correlations between saliva cortisol levels and
serum cortisol concentrations are high (23, 24).
Participants and their parents were instructed to
collect saliva at two time points during the morn-
ing; directly after waking up (approximately 7.00
A.M., while still lying in bed, sample 1), and half
an hour later (sample 2). In addition, saliva was
collected at 8.00 P.M. (sample 3). Parents of all
participants received written and oral instructions.
First, they received a letter containing information
about the purpose of saliva collection and some
background information about diurnal basal
cortisol levels. Then, a member of the team visited
them at home and gave further instructions. It was
stressed that it was important to collect saliva on a
normal day, during a normal week, without special
events or stressful circumstances. Parents were also
told that their child should not be ill, have a cold,
be menstruating, or take any medication on the
day of saliva collection. Furthermore, it was
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explained that participants should rinse their
mouth with tap water before sampling saliva, and
not consume sour products or brush their teeth
before sampling. Parents were encouraged to place
the ﬁrst salivette next to their childs bed, so that he
or she could collect the ﬁrst sample directly after
waking up. In addition, it was stressed that the
salivettes should be placed in a freezer directly after
saliva collection, and mailed to the institute as
soon as possible (but not on Fridays or Saturdays
in order to prevent unnecessary delay due to the
weekend). Finally, all instructions were also
handed out on an instruction form. If any of the
requirements were not met, parents could note this
down on an accompanying form. Information
from this form (e.g. deviant time of sampling)
was included in our database. In addition, suspi-
cious quality of the saliva (e.g. containing blood or
bread crumbs) was noted by our team in this
database. Preliminary analyses showed that these
factors were not signiﬁcantly related to the cortisol
levels, and did not diﬀer between the groups that
were investigated (individuals with persistently
low, decreasing, increasing or persistently high
anxiety levels).
Participants who did not return the salivettes
within a couple of months were sent a reminder
letter. In all, saliva samples of 1768 children
(79.3% of all TRAILS participants) were received.
For more characteristics of this study population
see Rosmalen et al. (25).The saliva samples were
stored at )20C until analysis. Previous studies
suggested that salivary cortisol levels are stable for
prolonged periods of time at )20C (26). After
completion of the data collection, all samples were
sent in one batch (frozen, by courier) to the
laboratory (Department of Clinical and Theoretical
Psychobiology, University of Trier, Germany) for
analyses.
Cortisol levels were determined with a competi-
tive solid phase time-resolved ﬂuorescence immuno-
assay with ﬂuorometric end-point detection
(DELFIA, dissociation-enhanced lanthanide ﬂuo-
rescent immunoassays). Ninety-six-well Maxisorb
microtiterplates (Nunc) were used, coated with
rabbit-anti-ovine immunoglobulin. After an incu-
bation period of 48 h at 4C, the plates were
washed with wash buﬀer (pH = 7.4) coated with
an ovine anti-cortisol antibody, and then incubated
again. Synthetic saliva mixed with cortisol in a
range from 0 to 100 nmol ⁄ l served as standards.
Standards, controls (saliva pools) and samples
were tested in duplicate wells. Fifty microlitres of
biotin-conjugated cortisol was added, and after
30 min of incubation the non-binding cortisol ⁄bio-
tin-conjugated cortisol was removed by washing.
Two-hundred microlitres europium-streptavidin
(Wallac, Turku, Finnland) was added to each
well and after 30 min and six times of washing,
200 ll enhancement solution was added (Pharma-
cia, Freiburg, Germany). Within 15 min on a
shaker, the enhancement solution induced ﬂuores-
cence that could be detected with a DELFIA-
Fluorometer (Wallac, Turku, Finnland). A
standard curve was generated and the cortisol
concentrations of the samples were calculated with
a computer program. The intra-assay coeﬃcient of
variation was between 4.0% and 6.7%, and the
corresponding inter-assay coeﬃcients of variation
between 7.1% and 9.0% (25).
To obtain an index for the cortisol awakening
response, we calculated the area under the curve
(AUC) of the two morning cortisol samples (6, 27).
The cortisol awakening response is a useful index
of HPA-axis activity, which is rather consistent,
shows good intra individual stability across time,
and appears to be useful for assessing subtle
changes in HPA-axis activity (27, 28). Previous
research has provided evidence for a signiﬁcant
genetic inﬂuence on the cortisol awakening
response and this response was found to be
independent of the time of awakening, manner of
awakening (spontaneously or by an alarm clock),
sleep duration, sleep quality, physical activity or
morning routines (5, 27, 28). Furthermore, the
cortisol awakening response has proved to be a
good index for uncovering associations between
HPA-axis activity and stress-related problems,
such as worrying, social stress, persisting pain
and burnout (6). Sample 3 was used to investigate
possible associations with evening cortisol levels.
Other individual characteristics. Some variables
might be associated with both cortisol and anxiety,
and might therefore play a confounding role in the
relationship between cortisol levels and anxiety
levels. In this sample, gender and wave 2Depression
were signiﬁcantly associated with the index for the
cortisol awakening response (AUC) andwithwave 2
Total Anxiety scores. Therefore, gender and wave 2
Depression were taken into account as possible
confounders.
Information regarding other possible con-
founders, such as age, pubertal stage, perinatal
variables (pregnancy duration, birth weight), body
mass index (BMI), and wave 1 and 2 disruptive
behaviour was also assessed in the TRAILS study,
but was not taken into account for this manuscript,
as these factors were not signiﬁcantly associated
with the cortisol measures and with wave 2 Total
Anxiety scores, and since addition of these factors
to the model did not change the investigated
Cortisol and pathways of anxiety
181
associations markedly. For the same reasons we
did not take into account wave 1 Total Anxiety
and Depression scores. Given the age-range of our
sample at wave 1 (10–12 years old), there was no
use of oral contraceptives (0%), and there was only
a very low number of smokers (87% of the selected
sample had never smoked, only 1% had smoked
seven times or more) at the time of cortisol
sampling. Therefore, these variables were also not
included in this study.
Statistical analyses
The cortisol measures were root-transformed and
centered to approximate a normal distribution and
to improve the interpretation of betas.
To test whether cortisol measures predicted
future anxiety levels, two sets of multiple linear
regression analyses were performed with wave 2
Total Anxiety scores as the dependent variable. In
the ﬁrst block of the ﬁrst set of regression analyses
AUC and gender were added as predictors. To
investigate possible gender diﬀerences in the asso-
ciation between AUC and wave 2 Total Anxiety
scores, the interaction between gender and AUC
was added as a predictor in the second block. To
investigate whether the association was speciﬁc for
anxiety, wave 2 Depression scores were added as a
predictor in the last block. The second set of
analyses was performed similarly, except that
evening cortisol levels – instead of AUC – and
the interaction between evening cortisol levels and
gender were added to the model.
As our interest particularly concerned the asso-
ciation between cortisol measures and the persis-
tence of anxiety, we tested whether cortisol values
diﬀered between individuals with persistently low,
decreasing, increasing, or persistently high anxiety
levels. Four groups were composed, using cut-oﬀ
scores based on the 50th percentile (P50, Total
Anxiety = 0.51) and the 80th percentile (P80,
Total Anxiety = 0.81) of the cumulative frequency
distribution of the wave 1 Total Anxiety scores.
The ﬁrst group, which consisted of individuals with
persistently low anxiety levels, scored below P50 on
the Total Anxiety scale at wave 1 and at wave 2
(n = 642). The second group, with decreasing
anxiety levels scored above P80 on the Total
Anxiety scale at wave 1 and below P50 on the
Total Anxiety scale at wave 2 (n = 125). The third
group consisted of individuals with increasing
anxiety levels, who scored below P50 on the
Total Anxiety scale at wave 1, but above P80 on
the Total Anxiety scale at wave 2 (n = 29). The
fourth group consisted of individuals with persis-
tently high anxiety levels who scored above P80 on
the Total Anxiety scale at wave 1 and at wave 2
(n = 91). We should note that of those high on
Total Anxiety at wave 1, about 50% was also high
on Depression at wave 1 (decreasers: 46%, persis-
tently high: 55%). Depression at wave 1 was
however not related to the cortisol levels, and
was therefore not taken into account as a
confounder.
For each group, descriptives were computed.
Diﬀerences between the groups concerning AUC
and evening cortisol levels were calculated using
one-way analyses of covariance, with gender and
wave 2 Depression scores as covariates. To detect
diﬀerences between the group with persistently
high anxiety levels and the other groups, contrasts
were calculated with the group with persistently
high anxiety levels as the reference group.
Results
Regression models
The index for the cortisol awakening response
(AUC) did not signiﬁcantly predict wave 2 Total
Anxiety scores in the ﬁrst block (Bauc = 0.017,
P = 0.32). Adding the interaction between AUC
and gender to the model did not reveal signiﬁcant
gender diﬀerences (block 2: Baucsex = 0.019,
P = 0.59). Addition of wave 2 Depression scores
did not reveal such gender diﬀerences either (block
3: Baucsex = )0.017, P = 0.47)
Evening cortisol levels also did not signiﬁcantly
predict wave 2 Total Anxiety scores in the ﬁrst
block (Bsample3 = )0.007, P = 0.65). Adding the
interaction between evening cortisol levels and
gender to the model also did not reveal signiﬁcant
gender diﬀerences (block 2: Bsample3sex=
)0.024, P = 0.45). Addition of wave 2 Depres-
sion scores did not reveal such gender diﬀer-
ences either (block 3: Bsample3sex=)0.012,
P = 0.59).
Group differences
Table 1 shows descriptives for each group (persis-
tently low, decreasing, increasing and persistently
high anxiety levels). Mean cortisol concentrations
throughout the day are shown for each group in
Fig. 1.
The one-way analyses of covariance did not
reveal an overall diﬀerence in AUC between the
four groups (F(3)=1.88, P = 0.13, g2 = 0.7%),
but post-hoc contrasts showed that AUC was
signiﬁcantly lower in individuals with persistently
high anxiety levels than in those with increasing
anxiety levels (P = 0.02). Individuals with persis-
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tently high anxiety levels did not diﬀer with respect
to AUC compared with the other groups (persis-
tently low, decreasing). As Fig. 1 shows, AUC
does not only seem to be higher in individuals with
increasing anxiety levels compared to those with
persistently high anxiety levels, but also compared
to those with persistently low or decreasing anxiety
levels. We tested this diﬀerence for signiﬁcance by
repeating the analyses, using the group with
increasing anxiety levels as the reference group.
These post-hoc analyses revealed that AUC was
also higher in individuals with increasing anxiety
levels when we compared this group to those with
decreasing anxiety levels (P = 0.05) or those with
persistently low anxiety levels (P = 0.05).
The second set of one-way analyses of covariance
revealed an overall diﬀerence in evening cortisol
levels between the four groups (F(3)=2.97,
P = 0.03, g2 = 1%). Post-hoc contrasts showed
that evening cortisol levels were lower in individuals
with persistently high anxiety levels than in those
with persistently low (P = 0.02), decreasing
(P = 0.04) or increasing (P = 0.01) anxiety
levels. These group-diﬀerences are also illustrated
in Fig. 1.
Finally, Table 1 shows that mean anxiety levels
at wave 1 are higher in individuals with increasing
anxiety levels than in the group with persistently
low anxiety levels. This is the case, while both
groups were composed using the same wave 1 cut-
oﬀ point (below P50 of the Total Anxiety scale). As
this diﬀerence could be important for the interpre-
tation of our ﬁndings, we tested this diﬀerence for
signiﬁcance by means of post-hoc one-way analysis
of covariance. We found that participants with
increasing anxiety levels had signiﬁcantly higher
baseline anxiety levels than those with persistently
low anxiety levels (F (1)=10.47, P < 0.01,
g2 = 1.5%).
Discussion
This study investigated the role of the HPA-axis in
the development of anxiety in early adolescence.
We tested the following hypotheses: i) high cortisol
levels predict high anxiety levels two years later,
ii) morning cortisol levels (AUC) are higher in
individuals with persistently high anxiety levels,
than in those with persistently low, decreasing, or
increasing anxiety levels, and iii) cortisol measures
are speciﬁcally associated with anxiety, as apart
from depression.
Our analyses revealed that baseline cortisol
measures did not predict anxiety levels 2 years
later in this general population sample. Moreover,
individuals with persistent anxiety problems did not
have higher morning cortisol levels (AUC) than
those with persistently low, decreasing, or increas-
ing levels of anxiety. Hence, although the TRAILS
study provided the opportunity to investigate
associations between cortisol measures and future
anxiety levels in a large, representative population
sample – and thus had the power to detect small
eﬀects – the eﬀects we expected were not found.
Thus, overall, we conclude that in the general
population, cortisol measures alone cannot be used
to identify individuals at risk for anxiety problems.




Decreasing anxiety (n = 125) Increasing anxiety (n = 29) Persistently high anxiety
(n = 91)
Mean (SD) Range Mean (SD) Range Mean (SD) Range Mean (SD) Range
Total Anxiety wave 1 0.30 (0.13) 0.00–0.49 1.05 (0.22) 0.81–1.97 0.38 (0.07) 0.22–0.49 1.13 (0.28) 0.81–2.08
Total Anxiety wave 2 0.21 (0.14) 0.00–0.49 0.31 (0.13) 0.00–0.49 0.98 (0.21) 0.81–1.59 1.10 (0.27) 0.81–2.14
Depression wave 1 0.42 (0.24) 0.00–1.20 0.95 (0.34) 0.30–2.10 0.55 (0.27) 0.10–1.10 1.00 (0.34) 0.00–1.90
Depression wave 2 0.23 (0.22) 0.00–1.10 0.38 (0.27) 0.00–1.20 0.92 (0.45) 0.30–2.20 1.02 (0.44) 0.10–2.50
































(n = 125)            
Increasers
(n = 29)             
Persistenly high
(n = 91)
Fig. 1. Mean cortisol concentrations throughout the day for
individuals with persistently low, decreasing, increasing, or
persistently high anxiety levels. Sample 1, directly after waking
up; sample 2, half an hour later; sample 3, 8 oclock in the
evening.
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Having said this, two signiﬁcant group
diﬀerences were found: The group with increasing
anxiety levels had a signiﬁcantly higher AUC
(especially the cortisol levels half an hour after
awakening) than the other groups (persistently
low, decreasing, persistently high). Further, the
group with persistently high anxiety levels had
signiﬁcantly lower evening cortisol levels than the
other groups (persistently low, decreasing, increas-
ing). Yet, the sizes of these eﬀects were small.
Theoretical considerations
Our ﬁndings do not provide clear evidence for
either the theory of Kagan et al. (7), who suggest
that high cortisol levels may underlie future anxiety
problems, or the theory of Gunnar and Vazquez
(11) that implies that stress during early develop-
ment may lead to lower cortisol levels. Having
stressed this, our ﬁnding of higher morning cortisol
levels (especially sample 2) in participants with
increasing anxiety levels is noteworthy. In this
group with increasing anxiety levels, an increase in
anxiety levels apparently involved a higher AUC
(i.e. increase in cortisol levels after awakening).
This could mean two things. First, it could be that,
in this particular group, higher HPA-axis activity,
especially after awakening, eventually lead to an
increase in anxiety levels, which would be in line
with the theory of Kagan et al. (7). This, however,
is not very likely, as our regression analyses did not
reveal that cortisol measures predicted future
anxiety levels. Second, it could be that, in this
particular group, an increase in anxiety levels went
hand in hand with an increase in cortisol levels
after awakening. In other words, as anxiety levels
increased, so did these morning cortisol levels. As
this group already had somewhat higher baseline
anxiety levels than the group with persistently low
anxiety levels, this explanation seems more likely.
Thus, this ﬁnding might indicate that a rise in
anxiety levels across time may be reﬂected in a rise
in cortisol levels after awakening.
Morning vs. evening cortisol levels
Although the eﬀect size was small, our ﬁnding of
lower evening cortisol levels in participants with
persistently high anxiety levels could be considered
as supportive of the theory of Gunnar and Vazquez
(11). Persistence of anxiety may ﬁrst have resulted
in higher cortisol levels, and, as a consequence, in
down-regulation of components of the HPA-axis
in the long run. This may explain the lower evening
cortisol levels in those individuals with persistent
anxiety. However, only evening cortisol levels were
lower, whereas morning levels were not. Hence, the
results do not support the Gunnar and Vazquez
theory unequivocally.
Since Feder et al. (10) also found lower evening
cortisol levels in anxious children, it might be
fruitful to further investigate this phenomenon.
Both higher morning cortisol levels and lower
evening cortisol levels have been associated with
anxiety. Previous research has shown that morning
cortisol levels are mainly determined by genetic
inﬂuences, while evening cortisol levels are mainly
inﬂuenced by environmental factors (27, 29).
Therefore, it is possible that the theories of
Kagan et al. (7) and of Gunnar and Vazquez (11)
both partly apply, be it for diﬀerent aspects of
HPA-axis functioning.
Anxiety vs. depression
Co-occurring depressive problems at wave 2 were
taken into account in all analyses. The associations
between the cortisol measures and certain develop-
mental trajectories of anxiety (increasing anxiety,
persistent anxiety) seemed to be speciﬁc for anxiety,
because these associations did not disappear when
we adjusted for co-occurring depressive problems
(wave 2, and preliminary analyses also did not
show diﬀerent results when controlling for wave 1
Depression). Apparently, the associations we found
between cortisol and anxiety do not seem to be
explained by the broad dimension of internalizing
problems, but seem to be quite speciﬁc for anxiety,
as apart from depression.
Previous vs. current findings
One may question why individuals with persis-
tently high anxiety levels did not have relatively
high cortisol levels, like we expected based on our
previous ﬁndings. It could be that, due to down-
regulation of components of the HPA-axis, the
cortisol levels of individuals with persistent anxiety
problems drop again (11). Yet, this does not
corroborate with our ﬁnding of higher morning
cortisol levels (AUC) in individuals with persistent
anxiety problems in our previous study (14). This
previous study concerned persistency of anxiety
problems over a 6–8-year period from early child-
hood (4 years old) to early adolescence
(10–12 years old), after which cortisol levels were
obtained. Anxiety levels at age 4 were assessed
retrospectively. In the current study, the persis-
tency of anxiety was measured prospectively, and
covered a 2-year period of early adolescence.
Cortisol levels were assessed at the start of this
period. It is possible that the association between
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HPA-axis activity and anxiety changes throughout
development. Therefore, it is important to investi-
gate this association during diﬀerent developmen-
tal periods. Further, since the period over which
persistency of anxiety was measured was longer in
the previous study, it might be that the association
between cortisol measures and the persistence of
anxiety becomes more evident when the persistence
of anxiety is measured over a longer period of time.
Possibly, cortisol levels increase after a long period
of anxiety problems, but high cortisol levels do not
predict the persistence of anxiety in the future.
Lastly, one should bear in mind that our previous
study relied on retrospective data, while the current
study was a prospective one, which implies that the
reliability of the anxiety data used in the current
study was almost certainly higher. Thus, ﬁndings
might diﬀer between the studies due to some
important methodological diﬀerences.
Methodological considerations
This study was carried out in a general population
sample. The theory of Kagan et al. (7) was based
on ﬁndings in small, select groups and other studies
often focused on clinical samples (30). Thus, as
anxiety levels are relatively low in our sample,
associations between cortisol levels and anxiety
might be diﬀerent in a sample with symptoms in
the (sub-)clinical range. We should also note that,
although we did control for co-occurring depres-
sion, individuals with high Depression scores were
not excluded, thus co-occurring depressive prob-
lems could have inﬂuenced our results to some
extent. Further, basal daytime cortisol measures
were assessed. Although our index of the cortisol
awakening response (AUC) reﬂects the response to
a so-called physical stressor – waking up –
measures of reactivity to relatively more stressful
stimuli, such as mental stress, might reveal diﬀerent
results. Finally, the present study had some limi-
tations. For instance, cortisol samples were col-
lected at home, which may have limited the
reliability of the time points at which cortisol
samples were assessed. Fortunately, deviant time of
sampling was not signiﬁcantly related to the
cortisol levels. It is however possible that the
small eﬀect sizes we found have been inﬂuenced by
a relatively lower reliability of the cortisol data.
Nevertheless, since the eﬀect sizes were particularly
small in this study, we may also conclude that
anxiety levels in young adolescents are probably
associated with many other factors as well. For
instance, the HPA-axis works in alliance with
many other physiological systems, such as the
immune system and the gonodal axis (31),
HPA-axis activity is triggered by environmental
inﬂuences, and HPA-axis functioning is at least
partially determined by genetic factors (27, 29, 32).
Therefore, focusing too much on HPA-axis
functioning alone in the search for aetiological
mechanisms may not prove to be very fruitful.
To conclude, this study did not reveal evidence for
a predictive association between baseline cortisol
measures and the development of anxiety in young
adolescents from the general population. We
therefore conclude that in the general population,
cortisol measures alone cannot be used to identify
individuals at risk for anxiety problems. We
question the extent to which the HPA-axis in
itself plays an important role in the aetiology of
anxiety, and we expect that the interaction of the
HPA-axis with other biological or environmental
factors will play a more important role.
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